Annabel..Your fathers genetic testing must reveal MMS- HIgh in order to receive Keytruda on it’s own. If that is not the case than testing for PD-L1must come back as positive, which in turn will allow him to enter the Merck clinical trial.
I am new on this site, not sure how it works, but just sent you email with question where in the Netherlands they offer Keytruda als treatment for CC. Since my mom recently has been diagnosed with this horrible disease. Just to make sure this message will be received I post it also on the site.
I have a question concerning my fathers cholangiocarcinoma. He has been participating in multiple trials, without even partial response. Now there’s the option to either start Sorafenib or Keytruda and I honestly don’t know what would be best for him. Do any of you know wich of the two has showed to be more promising? Does it depend on what biomarkers there were found in the tumors?
Help is much appreciated,
Viewing 7 posts - 1 through 7 (of 7 total)
The forum ‘Chemotherapy & More’ is closed to new topics and replies.